Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-20

Clinical Trial Update: Empower Neuromodulation System - Pilot Study for Anxiety Treatment [NA]

View source ↗

Summary

A pilot trial evaluating the Empower Neuromodulation System for generalized anxiety disorder has been terminated, with results posted (as of 2024-06-20).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Empower Neuromodulation System

Snippet

Sponsor: Theranova, L.L.C. | Conditions: Generalized Anxiety Disorder | NA | Status: TERMINATED | Results posted: 2024-06-20